Table 1 Demographic, Clinical Characteristics and secondary interventions of study cohort

Demographics

Sex (Female) ‒ n (%)

305 (43.8)

498 (63.4)

Age group ‒ n (%)

 18–60

542 (77.8)

540 (68.8)

 > 60

155 (22.2)

245 (31.2)

Clinical characteristics

Ischemic stroke (total number ≥ 1)—n (%)

275 (39.5)

29 (3.7)

Hemorrhagic stroke (total number ≥ 1)—n (%)

 < 6¹

 < 6¹

TIA (total number ≥ 1)—n (%)

67 (9.6)

15 (1.9)

Other CHD hospitalizations—n (%)

144 (20.7)

167 (21.3)

Peripheral embolism, pulmonary embolism, or DVT—n (%)

40 (5.7)

13 (1.7)

Dyslipidemia—n (%)

 < 6¹

 < 6¹

Thrombophilia—n (%)

 < 6¹

 < 6¹

Migraine—n (%)

81 (11.6)

31 (3.9)

Renal failure—n (%)

12 (1.7)

32 (4.1)

AF—n (%)

50 (7.2)

120 (15.3)

CAD—n (%)

114 (16.4)

166 (21.1)

CHF—n (%)

34 (4.9)

63 (8.0)

COPD—n (%)

93 (13.3)

97 (12.4)

Diabetes—n (%)

72 (10.3)

106 (13.5)

HTN—n (%)

258 (37.0)

302 (38.5)

Intervention codes²

Fluoroscopy, heart NEC without contrast—n (%)

20 (2.9)

26 (3.3)

Xray

 Thoracic cavity NEC—n (%)

41 (5.9)

17 (2.2)

 Intravenous contrast injection, coronary veins—n (%)

127 (18.2)

118 (15.0)

 Intraarterial contrast injection, pulmonary artery—n (%)

298 (42.8)

343 (43.7)

 Intracardiac contrast injection, pulmonary artery

39 (5.6)

10 (1.3)

Steady state respiratory function study—n (%)

134 (19.2)

85 (10.8)

Heart capacity measurement, oxygen consumption technique—n (%)

123 (17.6)

129 (16.4)

Pressure measurement—n (%)

169 (24.2)

318 (40.5)

Ultrasound heart NEC, cardiac catheter inspection—n (%)

52 (7.5)

70 (8.9)

Heart and coronary artery ultrasound—n (%)

55 (7.9)

115 (14.6)